![Clinical Nutrition Market Size Clinical Nutrition Market Summary](https://s3.mordorintelligence.com/global-medical-clinical-nutrition-market-industry/global-medical-clinical-nutrition-market-industry-size-image-1735448314978.webp)
Study Period | 2019 - 2030 |
Market Size (2025) | USD 78.11 Billion |
Market Size (2030) | USD 115.03 Billion |
CAGR (2025 - 2030) | 8.05 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Clinical Nutrition Market Analysis
The Clinical Nutrition Market size is estimated at USD 78.11 billion in 2025, and is expected to reach USD 115.03 billion by 2030, at a CAGR of 8.05% during the forecast period (2025-2030).
The clinical nutrition industry continues to evolve with changing healthcare dynamics and surgical requirements across different regions. According to recent data from the Organization for Economic Co-operation and Development, European countries have shown significant surgical volumes, with Portugal performing 94,870 surgeries, Denmark conducting 49,330 surgeries, and Ireland carrying out 32,840 surgeries in 2021. This substantial volume of surgical procedures has created a robust demand for specialized clinical nutrition products, particularly in pre- and post-operative care settings. The industry has responded by developing more targeted nutritional therapy solutions that address specific surgical recovery needs and optimize patient outcomes.
Product innovation and technological advancement have become cornerstone strategies in the clinical nutrition market, with manufacturers focusing on developing specialized formulations for various medical conditions. Companies are increasingly investing in research and development to create more effective and patient-friendly medical nutrition solutions. For instance, in August 2021, Esperer Nutrition demonstrated this trend by launching a comprehensive range of consumer nutraceuticals targeting specific health conditions, including bone and joint health, immunity, urinary tract health, sleep apnea, and pre-diabetic care. These innovations reflect the industry's shift toward more personalized therapeutic nutrition solutions that address specific patient needs.
The market has witnessed significant consolidation through strategic partnerships and acquisitions, as companies seek to expand their product portfolios and geographical presence. Major industry players are forming alliances to combine their technological capabilities and market expertise, resulting in more comprehensive medical nutrition solutions. These collaborations have led to improved product development processes and more efficient distribution networks, ultimately benefiting healthcare providers and patients. The industry has also seen increased investment in manufacturing capabilities to meet growing demand and ensure supply chain resilience.
Regulatory standards and clinical guidelines continue to shape the market landscape, with increasing emphasis on product quality and safety. Healthcare institutions and regulatory bodies are implementing stricter protocols for clinical nutrition products, particularly in specialized areas such as rare disease management. This is evidenced by the current prevalence rates of conditions like Gaucher disease, which affects 0.70 to 1.75 per 100,000 individuals globally, with birth incidence rates varying from 0.39 to 5.80 per 100,000 individuals. These statistics have prompted the development of more specialized nutritional therapy solutions and stricter quality control measures across the industry.
Clinical Nutrition Market Trends
Increasing Prevalence of Metabolic Disorders
Metabolism-related disorders have become increasingly prevalent worldwide, creating a significant demand for medical nutrition therapy products. According to the International Diabetes Federation (IDF), globally, there were 537 million people affected by diabetes aged between 20-79 years in 2021, with projections indicating this number could reach 783 million by 2045. The rising burden of metabolic disorders extends beyond diabetes to include conditions such as Gaucher's disease, glucose-galactose malabsorption, hereditary hemochromatosis, maple syrup urine disease (MSUD), and phenylketonuria (PKU), all of which require specialized medical food support for effective management.
The increasing prevalence of rare metabolic disorders also contributes significantly to the demand for clinical nutrition. For instance, Gaucher's disease has a worldwide prevalence of 0.70 to 1.75 per 100,000 individuals, with a standardized birth incidence varying from 0.39 to 5.80 per 100,000 individuals. Similarly, phenylketonuria affects approximately one in 10,000 babies born in the United Kingdom, with carriers of the altered gene having a one in four chance of passing the condition to their children. These conditions require lifelong dietary management and nutritional therapy support, as they can cause various complications including mental retardation, organ damage, and other serious health issues if not properly managed through appropriate nutritional intervention.
High Spending on Healthcare
The increasing global healthcare expenditure has become a significant driver for the clinical nutrition market, with voluntary spending on healthcare reaching unprecedented levels in many developed nations. Switzerland leads in voluntary healthcare spending with USD 2,372 per capita, followed by substantial expenditures in other developed nations such as Canada (USD 1,602 per capita) and Australia (USD 1,540 per capita). This increased healthcare spending directly correlates with greater investment in nutritional support and preventive care measures, including clinical nutrition products and services.
The out-of-pocket healthcare spending patterns also demonstrate a strong commitment to health-related expenditures across major economies. In the United States, out-of-pocket spending on healthcare reached USD 1,238 per capita, while Switzerland reported USD 1,805 per capita, and Korea showed USD 1,020 per capita. These significant investments in healthcare reflect a growing awareness of the importance of proper nutritional support in disease management and prevention. The increased spending capacity has enabled healthcare providers to implement more comprehensive nutritional care programs and has made clinical nutrition products more accessible to patients who require them for various medical conditions.
Growing Geriatric Population
The global demographic shift towards an aging population has emerged as a crucial driver for the clinical nutrition market. According to the United Nations Department of Economic and Social Affairs, there were 727 million persons aged 65 years or over worldwide in 2020, with projections indicating this number will more than double to reach over 1.5 billion by 2050. This significant increase in the elderly population creates a substantial demand for hospital nutrition products, as older adults are more susceptible to various health conditions that require nutritional support.
The impact of population aging is particularly noteworthy as the share of the global population aged 65 years or over is expected to increase from 9.3% in 2020 to 16.0% by 2050. This demographic transition is occurring across all regions, though at varying rates, with both developed and developing nations experiencing significant growth in their elderly populations. The aging population typically requires more intensive medical diet support due to various factors such as decreased appetite, reduced nutrient absorption capabilities, and higher prevalence of chronic diseases. These factors collectively contribute to an increased demand for specialized clinical nutrition products and services designed specifically for geriatric care.
Segment Analysis: By Route of Administration
Oral Segment in Clinical Nutrition Market
The oral route of administration continues to dominate the clinical nutrition market, commanding approximately 58% of the total market share in 2024. This significant market position is primarily driven by the preference of healthcare providers to prescribe oral nutritional supplements whenever possible, as it involves fewer complexities and costs compared to other routes of administration. The segment's strong performance is supported by the growing demand for medical nutritional supplements in managing chronic conditions like end-stage renal disease (ESRD), where specialized clinical nutrition helps reduce the burden on patients' kidneys. Additionally, the increasing availability of innovative oral nutritional products, including vegan options and specialized formulations for specific medical conditions, has further strengthened this segment's market position. The oral segment is also experiencing the fastest growth among all routes of administration, driven by its cost-effectiveness, ease of administration, and high patient compliance rates.
![Market Analysis of Clinical Nutrition Market: Chart for By Route of Administration](https://s3.mordorintelligence.com/global-medical-clinical-nutrition-market-industry/global-medical-clinical-nutrition-market-industry-Clinical-Nutrition-Market-Market-Share-by-Route-of-Administration-Segment-1737051898432.webp)
Enteral Segment in Clinical Nutrition Market
The enteral nutrition segment represents a crucial component of the clinical nutrition market, serving as a vital option for patients unable to consume food orally or those with impaired digestive systems. This segment has gained significant traction due to its effectiveness in providing life-sustaining nutrients through tube feeding nutrition. The segment's growth is being driven by technological advancements in enteral nutrition devices, increasing cases of chronic diseases requiring long-term nutritional support, and the rising adoption of enteral nutrition in intensive care units. Healthcare providers are increasingly recognizing the benefits of early enteral nutrition intervention in improving patient outcomes, particularly in critical care settings. The segment is also benefiting from the development of specialized formulations targeting specific medical conditions and the growing awareness about the importance of proper nutritional support in patient recovery.
Remaining Segments in Route of Administration
The parenteral nutrition segment, while smaller in market share, plays a vital role in the clinical nutrition market by providing essential nutrients directly into the bloodstream. This route of administration is crucial for patients who cannot receive nutrition through oral or enteral routes due to various medical conditions. The segment's importance is particularly evident in critical care settings, where patients may require complete bypass of the gastrointestinal tract. Despite its smaller market share, parenteral nutrition continues to be an indispensable component of clinical nutrition therapy, especially in cases of severe gastrointestinal disorders, post-surgical recovery, and certain oncology treatments. The segment is witnessing ongoing innovations in formulation development and delivery systems to enhance patient safety and treatment outcomes.
Segment Analysis: By Application
Malnutrition Support Segment in Clinical Nutrition Market
The nutritional support for malnutrition segment holds a dominant position in the global clinical nutrition market, accounting for approximately 26% of the market share in 2024. This significant market share is driven by the increasing global burden of malnutrition across various demographics, particularly affecting children under five years and the elderly population. The World Health Organization's continued focus on addressing malnutrition through various initiatives and guidelines has strengthened the segment's position. Healthcare facilities worldwide are increasingly implementing standardized nutrition screening protocols and intervention strategies, contributing to the segment's market leadership. The segment's growth is further supported by the rising awareness about the importance of clinical nutrition in preventing and treating malnutrition-related complications in both developed and developing countries.
Gastrointestinal Diseases Support Segment in Clinical Nutrition Market
The nutritional support for gastrointestinal diseases segment is emerging as the fastest-growing segment in the clinical nutrition market, projected to grow at approximately 8% during the forecast period 2024-2029. This remarkable growth is attributed to the increasing prevalence of gastrointestinal disorders worldwide and the growing recognition of nutrition's role in managing these conditions. The segment's expansion is further driven by technological advancements in enteral nutrition products specifically designed for patients with gastrointestinal complications. Healthcare providers are increasingly adopting specialized nutritional solutions for managing conditions such as inflammatory bowel disease, celiac disease, and other digestive disorders. The development of innovative formulations that enhance nutrient absorption and minimize gastrointestinal distress is also contributing to the segment's rapid growth.
Remaining Segments in Clinical Nutrition Market by Application
The clinical nutrition market encompasses several other vital segments, including nutritional support for metabolic disorders, cancer, neurological diseases, and kidney diseases. The metabolic disorders segment is particularly significant due to the rising prevalence of diabetes and other metabolic conditions. Cancer nutrition support continues to be crucial in managing treatment side effects and maintaining patient strength during therapy. The neurological diseases segment addresses the specific nutritional needs of patients with conditions like Alzheimer's and Parkinson's disease. Kidney disease nutrition support focuses on specialized formulations for patients undergoing dialysis and other renal treatments. Each of these segments plays a vital role in addressing specific patient populations' unique nutritional requirements and contributing to the overall market dynamics.
Segment Analysis: By End User
Pediatric Segment in Clinical Nutrition Market
The pediatric clinical nutrition segment continues to dominate the global clinical nutrition market, holding approximately 60% of the total market share in 2024. This significant market position is driven by the increasing prevalence of malnutrition among children worldwide and the growing awareness about the importance of proper nutrition in early childhood development. The segment's growth is further supported by the rising cases of premature births requiring specialized nutritional support, along with the increasing incidence of chronic diseases among children that necessitate clinical nutrition interventions. Healthcare providers and parents are increasingly recognizing the critical role of clinical nutrition in supporting children's growth, development, and recovery from various medical conditions. Additionally, the expansion of pediatric healthcare facilities worldwide and the introduction of innovative pediatric nutrition products tailored to specific medical conditions have contributed to maintaining this segment's dominant position in the market.
Adult Segment in Clinical Nutrition Market
The adult segment is emerging as the fastest-growing segment in the clinical nutrition market, projected to grow at a robust rate from 2024 to 2029. This accelerated growth is primarily attributed to the rising geriatric population globally and the increasing prevalence of chronic diseases among adults that require specialized nutritional support. The segment's expansion is further fueled by the growing awareness about the importance of clinical nutrition in post-operative recovery and disease management. Healthcare facilities are increasingly incorporating clinical nutrition as an essential component of treatment protocols for various medical conditions, including cancer, cardiovascular diseases, and metabolic disorders. The rise in lifestyle-related health issues, coupled with the growing adoption of enteral and parenteral nutrition in adult patient care, is driving the segment's rapid growth. Moreover, the development of personalized nutrition solutions and the increasing focus on preventive healthcare among adults are contributing to the segment's dynamic expansion in the clinical nutrition market.
Clinical Nutrition Market Geography Segment Analysis
Clinical Nutrition Market in North America
The North American clinical nutrition market demonstrates robust growth driven by advanced healthcare infrastructure, high healthcare spending, and increasing awareness about clinical nutrition. The United States leads the regional market, followed by Canada and Mexico. The region benefits from well-established distribution networks, a strong presence of key market players, and favorable reimbursement policies. The increasing prevalence of metabolic disorders and chronic diseases, coupled with a growing geriatric population, continues to drive market growth across these countries.
![Market Analysis of Clinical Nutrition Market: Forecasted Growth Rate by Region](https://s3.mordorintelligence.com/global-medical-clinical-nutrition-market-industry/global-medical-clinical-nutrition-market-industry-Clinical-Nutrition-Market-Forecasted-Five-Year-Growth-Rate-By-Region-1737130915335.webp)
Clinical Nutrition Market in United States
The United States dominates the North American clinical nutrition market with its well-established healthcare infrastructure and increasing healthcare expenditure. The country maintains its significant market position through continuous product innovations and launches by major market players. With approximately 82% market share in North America, the U.S. market is driven by the rising prevalence of chronic diseases, a growing geriatric population, and increasing awareness about clinical nutrition. The country's robust healthcare system, coupled with favorable reimbursement policies, continues to support market growth. The presence of leading market players and their focus on research and development further strengthens the market position.
Clinical Nutrition Market in Mexico
Mexico emerges as a promising market in North America with an expected growth rate of around 6% during 2024-2029. The country's clinical nutrition market is witnessing significant developments in terms of product innovation and distribution network expansion. Mexico's healthcare sector is experiencing rapid transformation with an increasing focus on nutritional therapy and disease management. The growing prevalence of chronic diseases and metabolic disorders, coupled with rising healthcare awareness, drives market growth. The country also benefits from increasing investments in healthcare infrastructure and a growing presence of international market players.
Clinical Nutrition Market in Europe
The European clinical nutrition market showcases strong growth potential supported by advanced healthcare systems and an increasing focus on preventive healthcare. The region comprises key markets including Germany, the United Kingdom, France, Italy, Spain, and Switzerland. Each country contributes significantly to the regional market growth through robust healthcare infrastructure and increasing adoption of clinical nutrition products. The market benefits from favorable healthcare policies, growing awareness about nutritional therapy, and the presence of major market players.
Clinical Nutrition Market in Germany
Germany maintains its leadership position in the European clinical nutrition market with approximately 26% market share. The country's market is characterized by strong healthcare infrastructure, high healthcare spending, and the presence of key market players. Germany's focus on research and development, coupled with the increasing prevalence of chronic diseases and a growing geriatric population, drives market growth. The country's healthcare system strongly supports nutritional therapy, leading to higher adoption of clinical nutrition products. Advanced medical facilities and increasing awareness about preventive healthcare further strengthen the market.
Clinical Nutrition Market in United Kingdom
The United Kingdom demonstrates impressive growth potential with an expected growth rate of around 7% during 2024-2029. The country's clinical nutrition market benefits from continuous technological advancements and product innovations. The UK's healthcare system strongly emphasizes nutritional therapy as part of treatment protocols, driving market growth. The increasing prevalence of chronic diseases and a growing geriatric population further boost market development. The country's focus on research and development, coupled with a strong presence of market players, supports sustained market growth.
Clinical Nutrition Market in Asia-Pacific
The Asia-Pacific clinical nutrition market exhibits significant growth potential driven by improving healthcare infrastructure, increasing healthcare expenditure, and growing awareness about nutritional therapy. The region encompasses major markets including China, Japan, India, Australia, and South Korea. Each country contributes uniquely to the regional market growth through various factors such as population demographics, healthcare policies, and economic development. The market witnesses increasing investments in healthcare infrastructure and a growing presence of international players.
Clinical Nutrition Market in China
China leads the Asia-Pacific clinical nutrition market through its extensive healthcare network and large patient population. The country's market benefits from continuous healthcare reforms and an increasing focus on preventive healthcare. China's growing geriatric population and rising prevalence of chronic diseases drive market growth. The country's healthcare system increasingly recognizes the importance of clinical nutrition in patient care. Strong government support for healthcare development and the presence of both domestic and international players strengthen the market position.
Clinical Nutrition Market in India
India emerges as the fastest-growing market in the Asia-Pacific region, driven by improving healthcare infrastructure and increasing healthcare awareness. The country's clinical nutrition market benefits from rising healthcare expenditure and a growing focus on preventive healthcare. India's large population base and increasing prevalence of lifestyle-related diseases create significant market opportunities. The country witnesses growing investments in healthcare infrastructure and an increasing presence of international market players. Government initiatives to improve healthcare accessibility further support market growth.
Clinical Nutrition Market in Middle East & Africa
The Middle East & Africa clinical nutrition market demonstrates steady growth potential driven by improving healthcare infrastructure and increasing healthcare awareness. The region includes key markets such as GCC countries and South Africa. The market benefits from growing healthcare expenditure and an increasing focus on preventive healthcare. Among these markets, GCC countries lead in terms of market size, while South Africa shows the fastest growth rate. The region witnesses increasing investments in healthcare infrastructure and a growing presence of international market players.
Clinical Nutrition Market in South America
The South American clinical nutrition market shows promising growth potential supported by improving healthcare infrastructure and increasing healthcare awareness. The region comprises key markets including Brazil and Argentina. The market benefits from growing healthcare expenditure and an increasing focus on preventive healthcare. Brazil leads the regional market in terms of size, while also demonstrating the fastest growth rate. The region witnesses continuous improvements in healthcare infrastructure and an increasing presence of international market players, supporting overall market development.
Clinical Nutrition Industry Overview
Top Companies in Clinical Nutrition Market
The clinical nutrition market features several prominent companies focusing on continuous innovation and strategic expansion. Companies are actively investing in research and development to create advanced nutritional formulations, particularly in areas like parenteral nutrition, infant formula, and specialized therapeutic nutrition products. The industry witnesses frequent product launches targeting specific medical conditions and patient demographics. Operational excellence is being achieved through the modernization of manufacturing facilities, supply chain optimization, and digital transformation initiatives. Strategic partnerships with healthcare providers, research institutions, and technology companies are becoming increasingly common to enhance market presence. Geographic expansion, particularly in emerging markets, remains a key focus area with companies establishing local manufacturing facilities and distribution networks to better serve regional demands.
Consolidated Market Led By Global Players
The clinical nutrition market demonstrates a relatively consolidated structure dominated by large multinational corporations with diverse healthcare portfolios. These major players leverage their extensive research capabilities, established distribution networks, and strong brand recognition to maintain market leadership. Local players maintain significance in specific regions by offering customized products suited to local preferences and regulations. The market witnesses active participation from both specialized nutrition companies and diversified healthcare conglomerates, with the latter benefiting from synergies across their various business segments.
Merger and acquisition activities remain robust as companies seek to expand their product portfolios, enhance technological capabilities, and strengthen geographic presence. Large companies frequently acquire innovative startups and regional players to gain access to new technologies, specialized product lines, or established local market positions. Strategic collaborations and joint ventures are common, particularly for entering new markets or developing innovative nutritional solutions. Companies are increasingly focusing on vertical integration to ensure quality control and supply chain efficiency.
Innovation and Adaptability Drive Market Success
Success in the clinical nutrition market increasingly depends on companies' ability to innovate and adapt to changing healthcare needs. Market leaders are strengthening their positions through continuous investment in research and development, focusing on personalized nutrition solutions and condition-specific formulations. Building strong relationships with healthcare providers and maintaining high-quality standards while ensuring cost competitiveness are crucial strategies. Companies are also expanding their digital capabilities to enhance customer engagement and streamline distribution channels.
For emerging players and market contenders, success lies in identifying and serving niche market segments or underserved geographic regions. Developing innovative delivery systems, focusing on natural and organic ingredients, and offering cost-effective alternatives to premium products are key strategies for gaining market share. The regulatory environment plays a crucial role, with companies needing to maintain compliance while adapting to evolving standards across different regions. The risk of substitution remains moderate, primarily mitigated by the specialized nature of medical nutrition products and their essential role in medical care.
Clinical Nutrition Market Leaders
-
Abbott Nutrition
-
Nestle Health Science
-
Baxter Healthcare
-
Danone
-
B. Braun SE
- *Disclaimer: Major Players sorted in no particular order
![Clinical Nutrition Market Concentration](https://s3.mordorintelligence.com/global-medical-clinical-nutrition-market-industry/global-medical-clinical-nutrition-market-industry_1668777113531_Picture2.webp)
Clinical Nutrition Market News
- October 2022: Hologram Sciences, and Maeil Health Nutrition entered into a strategic partnership to deliver personalized nutrition solutions to the Korean market.
- April 2022: Glanbia Nutritionals launched TechVantage a functionally optimized nutrient technology platform, which will provide customers with nutrient solutions.
Clinical Nutrition Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Metabolic Disorders
- 4.2.2 High Spending on Healthcare
- 4.2.3 Growing Geriatric Population
-
4.3 Market Restraints
- 4.3.1 Imprecise Perception About Clinical Nutrition
- 4.3.2 Reduction in Birth Rates
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Route of Administration
- 5.1.1 Oral and Enteral
- 5.1.2 Parenteral
-
5.2 By Application
- 5.2.1 Nutritional Support for Malnutrition
- 5.2.2 Nutritional Support for Metabolic Disorders
- 5.2.3 Nutritional Support for Gastrointestinal Diseases
- 5.2.4 Nutritional Support for Cancer
- 5.2.5 Nutritional Support in Neurological Diseases
- 5.2.6 Nutritional Support in Other Diseases
-
5.3 By End User
- 5.3.1 Pediatric
- 5.3.2 Adult
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories (Abbott Nutrition)
- 6.1.2 Nestle Health Science
- 6.1.3 Baxter Healthcare
- 6.1.4 B. Braun SE
- 6.1.5 Danone (Nutricia)
- 6.1.6 Perrigo Company PLC
- 6.1.7 Fresenius Kabi
- 6.1.8 AYMES International Ltd
- 6.1.9 Reckitt Benckiser
- 6.1.10 Medifood International Ltd
- 6.1.11 Ajinomoto Cambrooke Inc. (Nualtra Ltd)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Clinical Nutrition Industry Segmentation
As per the scope, clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. A higher number of premature births also demand advanced clinical nutrition. The Clinical Nutrition Market is Segmented by Route of Administration (Oral and Enteral, and Parenteral), Application (Nutritional Support in Malnutrition, Nutritional Support in Metabolic Disorders, Nutritional Support in Gastrointestinal Diseases, Nutritional Support in Neurological Diseases, Nutritional Support in Cancer, and Nutritional Support in Other Diseases), End User (Pediatric and Adult), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Route of Administration | Oral and Enteral | ||
Parenteral | |||
By Application | Nutritional Support for Malnutrition | ||
Nutritional Support for Metabolic Disorders | |||
Nutritional Support for Gastrointestinal Diseases | |||
Nutritional Support for Cancer | |||
Nutritional Support in Neurological Diseases | |||
Nutritional Support in Other Diseases | |||
By End User | Pediatric | ||
Adult | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Clinical Nutrition Market Research FAQs
How big is the Clinical Nutrition Market?
The Clinical Nutrition Market size is expected to reach USD 78.11 billion in 2025 and grow at a CAGR of 8.05% to reach USD 115.03 billion by 2030.
What is the current Clinical Nutrition Market size?
In 2025, the Clinical Nutrition Market size is expected to reach USD 78.11 billion.
Who are the key players in Clinical Nutrition Market?
Abbott Nutrition, Nestle Health Science, Baxter Healthcare, Danone and B. Braun SE are the major companies operating in the Clinical Nutrition Market.
Which is the fastest growing region in Clinical Nutrition Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Clinical Nutrition Market?
In 2025, the North America accounts for the largest market share in Clinical Nutrition Market.
What years does this Clinical Nutrition Market cover, and what was the market size in 2024?
In 2024, the Clinical Nutrition Market size was estimated at USD 71.82 billion. The report covers the Clinical Nutrition Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Clinical Nutrition Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Clinical Nutrition Market Research
Mordor Intelligence provides a comprehensive analysis of the clinical nutrition market. We leverage our extensive expertise in the medical nutrition industry to deliver detailed coverage of key segments. These include parenteral nutrition, enteral nutrition, and the medical food sectors. Our report examines crucial developments in therapeutic nutrition and medical nutrition therapy. It also offers detailed insights into MCN industry trends and innovations in hospital nutrition practices.
Stakeholders across the clinical nutrition industry benefit from our thorough analysis. We cover intensive care nutrition protocols and pediatric clinical nutrition requirements. The report, available as an easy-to-download PDF, discusses emerging developments in tube feeding nutrition technologies and oral clinical nutrition solutions. Our research provides valuable insights into medical nutritional supplements and medical diet considerations. It also explores evolving nutritional therapy approaches, enabling healthcare providers and industry participants to make informed decisions based on current market dynamics and future projections.